Delisting risk
Matinas BioPharma (MTNB)
Developer of lipid nanocrystal delivery technology for oral antifungal treatment.
$0.2047
Pre-market+0.02 (+7.91%)
At close$0.1897(−4.05%)
Something off on this page? Send us feedback.
Next report
Nov 12, 2026
in 70 days
EPS estimate
−$1.32
Revenue estimate
$25.0K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25Apr '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$1.50−$1.68−$1.03−$0.40−$0.30−$0.30−$0.21Pending
Estimate−$0.78−$0.78——−$0.78−$1.32−$1.32−$1.32
Surprise−92.3%−115.4%——+61.5%+77.2%+84.1%—
RevenueReportedEstimate
Mar '25Apr '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$962.0K——————Pending
Estimate————$25.0K$25.0K$25.0K$25.0K
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.32 | — | — |
| Aug 2026 | −$1.32 | −$0.21 | +84.1% |
| May 2026 | −$1.32 | −$0.30 | +77.2% |
| Mar 2026 | −$0.78 | −$0.30 | +61.5% |
| Nov 2025 | — | −$0.40 | — |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| Apr 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Apr 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Apr 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$1.32 | — | — | $25.0K | — | — | — |
| Aug 13, 2026 | −$1.32 | −$0.21 | +84.1% | $25.0K | — | — | −2.9% |
| May 8, 2026 | −$1.32 | −$0.30 | +77.2% | $25.0K | — | — | +0.3% |
| Mar 31, 2026 | −$0.78 | −$0.30 | +61.5% | $25.0K | — | — | +10.0% |
| Nov 10, 2025 | — | −$0.40 | — | — | — | — | +2.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 14, 2025 | |||||||
| Apr 15, 2025 | |||||||
| Mar 26, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 27, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 10, 2023 | |||||||
| Mar 15, 2023 | |||||||
| Nov 2, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 8, 2022 | |||||||
| Nov 8, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 29, 2021 | |||||||
| Nov 6, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 11, 2020 | |||||||
| Mar 9, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Aug 13, 2019 | |||||||
| May 13, 2019 | |||||||
| Apr 2, 2019 | |||||||
| Nov 12, 2018 | |||||||
| Aug 10, 2018 | |||||||
| May 10, 2018 | |||||||
| Mar 26, 2018 | |||||||
| Nov 15, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 16, 2017 | |||||||
| Apr 3, 2017 | |||||||
| Nov 15, 2016 | |||||||
| Aug 15, 2016 | |||||||
| May 13, 2016 | |||||||
| Mar 30, 2016 | |||||||
| Nov 10, 2015 | |||||||
| Aug 13, 2015 | |||||||